Abstract
How instalment and outcomes-based payment models are being written for curative therapies.
Description
Presented in “Cell and Gene Therapy: Manufacturing to Market”.
About the Speaker
KM
Q&A for Outcomes-Based Agreements for One-Off Therapies
Sign in to vote on questions.
Details
Duration45 min
RoomHall B (L2-HALL-B)
Tags
#live-day#translational-medicine
This Session
Cell and Gene Therapy: Manufacturing to Market
3:10 pm – 4:40 pm
Hall B
1 talk in this session
View SessionOther Talks in This Session